Niacinamide

Niacinamide

SCHEMBL4101623

CC(C)=O.NC(=O)c1cccnc1

nearest known ligand 0.88

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F7 P08709 1/20 0.88
F3 P13726 1/20 0.88
SARM1 Q6SZW1 1/20 0.88
SIRT2 Q8IXJ6 1/20 0.88
SIRT6 Q8N6T7 1/20 0.88
SIRT1 Q96EB6 1/20 0.88
SIRT3 Q9NTG7 1/20 0.88
SIRT5 Q9NXA8 1/20 0.88
SIRT4 Q9Y6E7 1/20 0.88
ALDH1A1 P00352 2/20 0.59
GAA P10253 2/20 0.59
APP P05067 1/20 0.59
HCAR3 P49019 1/20 0.59
HCAR2 Q8TDS4 1/20 0.59
MKNK1 Q9BUB5 3/20 0.58
MKNK2 Q9HBH9 3/20 0.58
HDAC1 Q13547 1/20 0.53
HDAC6 Q9UBN7 1/20 0.53
LMNA P02545 2/20 0.50
POLB P06746 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Niacinamide SCHEMBL28744959 0.96 F7 (0.88) F7F3SARM1SIRT2SIRT6
Niacinamide SCHEMBL18443774 0.94 F7 (0.85) F7F3SARM1SIRT2SIRT6
Niacinamide SCHEMBL28307211 0.94 F7 (0.85) F7F3SARM1SIRT2SIRT6
Niacinamide SCHEMBL5712652 0.94 F7 (0.92) F7F3SARM1SIRT2SIRT6
Niacinamide SCHEMBL27671762 0.94 F7 (0.92) F7F3SARM1SIRT2SIRT6
Niacinamide SCHEMBL2926 0.94
Niacinamide SCHEMBL19978192 0.94
Niacinamide SCHEMBL29624874 0.94
Niacinamide SCHEMBL460466 0.94 F7 (1.00) F7F3SARM1SIRT2SIRT6
Niacinamide SCHEMBL20298468 0.92 F7 (0.88) F7F3SARM1SIRT2SIRT6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115572710-A Method for serum-free hypoxia culture of mesenchymal stem cells 内蒙古蒙科干细胞基因医学研究有限公司 2023-01-06 CN claimed
CN-115572710-A Method for serum-free hypoxia culture of mesenchymal stem cells 内蒙古蒙科干细胞基因医学研究有限公司 2023-01-06 CN disclosed
US-20090111759-A1 Synergistic Combination of Glutamate-and Gaba-Gated Chloride Agonist Pesticide and at Least One Vitamin E, Niacin, or Derivatives Thereof CHEMINOVA A/S (DK) 2009-04-30 US disclosed
EP-1998621-A2 SYNERGISTIC COMBINATION OF GLUTAMATE- AND GABA-GATED CHLORIDE AGONIST PESTICIDE AND AT LEAST ONE OF VITAMIN E, NIACIN, OR DERIVATIVES THEREOF Cheminova A/S (DK) 2008-12-10 EP disclosed
EP-1849363-A1 Synergistic combination of glutamate- and GABA-gated chloride agonist pesticide and at least one of Vitamin E or Niacin Cheminova A/S (DK) 2007-10-31 EP disclosed
WO-2007101447-A2 SYNERGISTIC COMBINATION OF GLUTAMATE-AND GABA-GATED CHLORIDE AGONIST PESTICIDE AND AT LEAST ONE OF VITAMIN E, NIACIN, OR DERIVATIVES THEREOF CHEMINOVA A/S (DK) 2007-09-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090111759-A1 Synergistic Combination of Glutamate-and Gaba-Gated Chloride Agonist Pesticide and at Least One Vitamin E, Niacin, or Derivatives Thereof SLC6A1, GABRE, GRIN1 F7 3785/4885F3 4618/4885SARM1 451/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.